2011 annual financial data

Alaunos Therapeutics 2011 Net margin

Direct answer

Net margin was -9,561.92%.

Operating income was -71,400,000 USD and net income was -63,778,000 USD.
Operating cash flow was -38,835,000 USD.

Get free Alaunos Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
667,000 USD
Operating income
-71,400,000 USD
Net income
-63,778,000 USD
Operating cash flow
-38,835,000 USD